377460002: Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Plant material-containing product\Product containing phytochemical (product)\Rauwolfia alkaloid-containing product\Product containing rauwolfia alkaloid in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Plant material-containing product\Product containing phytochemical (product)\Rauwolfia alkaloid-containing product\Product containing reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine and hydrochlorothiazide and reserpine only product\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Plant material-containing product\Product containing phytochemical (product)\Rauwolfia alkaloid-containing product\Product containing reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Plant material-containing product\Product containing phytochemical (product)\Rauwolfia alkaloid-containing product\Product containing reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Plant material-containing product\Plant agent product\Rauwolfia alkaloid-containing product\Product containing rauwolfia alkaloid in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Plant material-containing product\Plant agent product\Rauwolfia alkaloid-containing product\Product containing reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine and hydrochlorothiazide and reserpine only product\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Plant material-containing product\Plant agent product\Rauwolfia alkaloid-containing product\Product containing reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Plant material-containing product\Plant agent product\Rauwolfia alkaloid-containing product\Product containing reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet

\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Hydralazine-containing product\Product containing hydralazine and hydrochlorothiazide (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine and hydrochlorothiazide and reserpine only product\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Hydralazine-containing product\Product containing hydralazine and hydrochlorothiazide (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Hydralazine-containing product\Product containing hydralazine and hydrochlorothiazide (medicinal product)\Product containing hydralazine and hydrochlorothiazide in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Hydralazine-containing product\Hydralazine-containing product in oral dose form\Product containing hydralazine and hydrochlorothiazide in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing benzothiadiazine (product)\Hydrochlorothiazide-containing product\Product containing hydralazine and hydrochlorothiazide (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine and hydrochlorothiazide and reserpine only product\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing benzothiadiazine (product)\Hydrochlorothiazide-containing product\Product containing hydralazine and hydrochlorothiazide (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing benzothiadiazine (product)\Hydrochlorothiazide-containing product\Product containing hydralazine and hydrochlorothiazide (medicinal product)\Product containing hydralazine and hydrochlorothiazide in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing benzothiadiazine (product)\Hydrochlorothiazide-containing product\Hydrochlorothiazide-containing product in oral dose form\Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing benzothiadiazine (product)\Hydrochlorothiazide-containing product\Hydrochlorothiazide-containing product in oral dose form\Product containing hydralazine and hydrochlorothiazide in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing benzothiadiazine (product)\Hydrochlorothiazide-containing product\Product containing hydrochlorothiazide and reserpine (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine and hydrochlorothiazide and reserpine only product\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing benzothiadiazine (product)\Hydrochlorothiazide-containing product\Product containing hydrochlorothiazide and reserpine (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing benzothiadiazine (product)\Hydrochlorothiazide-containing product\Product containing hydrochlorothiazide and reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing alkaloid (product)\Product containing naturally occurring alkaloid (product)\Rauwolfia alkaloid-containing product\Product containing rauwolfia alkaloid in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing alkaloid (product)\Product containing naturally occurring alkaloid (product)\Rauwolfia alkaloid-containing product\Product containing reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine and hydrochlorothiazide and reserpine only product\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing alkaloid (product)\Product containing naturally occurring alkaloid (product)\Rauwolfia alkaloid-containing product\Product containing reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine (medicinal product)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Medicinal product categorized by structure (product)\Product containing alkaloid (product)\Product containing naturally occurring alkaloid (product)\Rauwolfia alkaloid-containing product\Product containing reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine (medicinal product)\Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet

\Product manufactured as oral dose form (product)\Product containing rauwolfia alkaloid in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Product manufactured as oral dose form (product)\Hydrochlorothiazide-containing product in oral dose form\Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Product manufactured as oral dose form (product)\Hydrochlorothiazide-containing product in oral dose form\Product containing hydralazine and hydrochlorothiazide in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
\Product manufactured as oral dose form (product)\Hydralazine-containing product in oral dose form\Product containing hydralazine and hydrochlorothiazide in oral dose form (medicinal product form)\Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form\Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form\Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3699880012 Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3699881011 Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1202779011 Hydralazine hydrochloride + hydrochlorothiazide + reserpine 25mg/15mg/0.1mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1215632019 Hydralazine hydrochloride + hydrochlorothiazide + reserpine 25mg/15mg/0.1mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1215632019 Hydralazine hydrochloride + hydrochlorothiazide + reserpine 25mg/15mg/0.1mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1478817011 Hydralazine hydrochloride+hydrochlorothiazide+reserpine 25mg/15mg/0.1mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3490498017 Product containing hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3491849013 Product containing hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3501714019 Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3569373014 Product containing only hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3569374015 Product containing only hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3699879014 Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3699880012 Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3699881011 Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Is a	Hydrochlorothiazide-containing product	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Is a	Hydralazine-containing product	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Hydralazine	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Hydrochlorothiazide (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Is a	Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Hydralazine hydrochloride	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Centrally acting hypotensive agent	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Reserpine	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has manufactured dose form	A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has manufactured dose form	Conventional release oral tablet (dose form)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Is a	Hydralazine-containing product in oral dose form	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Is a	Hydrochlorothiazide-containing product in oral dose form	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength numerator unit (attribute)	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Reserpine	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	Reserpine	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength numerator value	0.1	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength numerator unit (attribute)	mg	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength numerator unit (attribute)	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Hydralazine hydrochloride	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	Hydralazine hydrochloride	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength numerator value	25	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	Reserpine	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	Hydralazine hydrochloride	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength numerator value	25	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Hydrochlorothiazide (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	Hydrochlorothiazide (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength numerator value	15	false	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Is a	Product containing hydrochlorothiazide and reserpine (medicinal product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has precise active ingredient	Hydralazine hydrochloride	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Is a	Product containing rauwolfia alkaloid in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has precise active ingredient	Hydrochlorothiazide (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has precise active ingredient	Reserpine	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Is a	Product containing hydralazine and hydrochlorothiazide in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Count of base of active ingredient	trois	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength numerator value	10^2	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength numerator unit (attribute)	mcg	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Is a	Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Plays role	Diuretic therapeutic role	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has precise active ingredient	Hydralazine hydrochloride	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has precise active ingredient	Reserpine	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has presentation strength numerator unit (attribute)	mcg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3699880012	Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3699881011	Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1202779011	Hydralazine hydrochloride + hydrochlorothiazide + reserpine 25mg/15mg/0.1mg tablet (product)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1215632019	Hydralazine hydrochloride + hydrochlorothiazide + reserpine 25mg/15mg/0.1mg tablet	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1215632019	Hydralazine hydrochloride + hydrochlorothiazide + reserpine 25mg/15mg/0.1mg tablet	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1478817011	Hydralazine hydrochloride+hydrochlorothiazide+reserpine 25mg/15mg/0.1mg tablet	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3490498017	Product containing hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg/1 each oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3491849013	Product containing hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg/1 each oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3501714019	Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3569373014	Product containing only hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg/1 each oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3569374015	Product containing only hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg/1 each oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3699879014	Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3699880012	Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3699881011	Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core